E-LIB Suche - Ergebnisse für: Jawa, Vibha

1

Preexisting antibody assays for gene therapy: Consideration..:

Braun, Manuela ; Lange, Claudia ; Schatz, Philipp...
Molecular Therapy - Methods & Clinical Development. 32 (2024) 1 - p. 101217 , 2024

Link: https://doi.org/10.1016/..

2

A High Threshold of Biotherapeutic Aggregate Numbers is Nee..:

Cohen, Joseph R. ; Brych, Stephen R. ; Prabhu, Siddharth...
Pharmaceutical Research. 41 (2024) 4 - p. 651-672 , 2024

Link: https://doi.org/10.1007/..

3

Immunogenicity Risk Assessment of Process-Related Impuritie..:

Mora, Johanna ; Forman, Daron ; Hu, Jennifer...
Journal of Pharmaceutical Sciences. , 2024

Link: https://doi.org/10.1016/..

4

PK/PD and Bioanalytical Considerations of AAV-Based Gene Th..:

Kavita, Uma ; Sun, Kefeng ; Braun, Manuela...
The AAPS Journal. 25 (2023) 5 - p. , 2023

Link: https://doi.org/10.1208/..

5

Evaluation of Cellular Immune Response to Adeno-Associated ..:

Gorovits, Boris ; Azadeh, Mitra ; Buchlis, George...
The AAPS Journal. 25 (2023) 3 - p. , 2023

Link: https://doi.org/10.1208/..

6

An Overview of Current Accomplishments and Gaps of COVID-19..:

Kale, Akanksha ; Gaur, Amitabh ; Menon, Ipshita...
Journal of Pharmaceutical Sciences. 112 (2023) 5 - p. 1345-1350 , 2023

Link: https://doi.org/10.1016/..

7

Understanding preclinical and clinical immunogenicity risks..:

Sauna, Zuben E. ; Jawa, Vibha ; Balu-Iyer, Sathy.
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

8

An IQ Consortium Perspective on Best Practices for Bioanaly..:

Gokemeijer, Jochem ; Balasubramanian, Nanda ; Ogasawara, Ken...
Clinical Pharmacology & Therapeutics. 115 (2023) 2 - p. 188-200 , 2023

Link: https://doi.org/10.1002/..

9

Best Practices and Considerations for Clinical Pharmacology..:

Mody, Hardik ; Ogasawara, Ken ; Zhu, Xu...
Clinical Pharmacology & Therapeutics. 114 (2023) 3 - p. 530-557 , 2023

Link: https://doi.org/10.1002/..

10

Bioanalytical Methods for Characterization of CAR‐T Cellula..:

Masilamani, Madhan ; Jawa, Vibha ; Dai, Yanshan...
Clinical Pharmacology & Therapeutics. 114 (2023) 3 - p. 664-672 , 2023

Link: https://doi.org/10.1002/..

11

Comparison of Pre-existing Anti-AAV8 Total Antibody Screeni..:

Dai, Yanshan ; Dong, Huijin ; Gleason, Carol...
The AAPS Journal. 25 (2023) 3 - p. , 2023

Link: https://doi.org/10.1208/..

12

Survey Outcome on Immunogenicity Risk Assessment Tools for ..:

Gokemeijer, Jochem ; Wen, Yi ; Jawa, Vibha...
The AAPS Journal. 25 (2023) 4 - p. , 2023

Link: https://doi.org/10.1208/..

13

Comparison of Titer and Signal to Noise (S/N) for Determina..:

Starcevic Manning, Marta ; Hassanein, Mohamed ; Partridge, Michael A....
The AAPS Journal. 24 (2022) 4 - p. , 2022

Link: https://doi.org/10.1208/..

14

Immunogenicity assessment of AAV-based gene therapies: An I..:

Yang, Tong-yuan ; Braun, Manuela ; Lembke, Wibke...
Molecular Therapy - Methods & Clinical Development. 26 (2022) - p. 471-494 , 2022

Link: https://doi.org/10.1016/..

15

Implementing a Clinical Immunogenicity Strategy using Precl..:

Jawa, Vibha ; Maamary, Jad ; Swanson, Michael..
Journal of Pharmaceutical Sciences. 111 (2022) 4 - p. 960-969 , 2022

Link: https://doi.org/10.1016/..